Wrinkles, destruction of barrier after aesthetic medicine
Conditions
Interventions
Test group:Ultrasound therapy and treatment using test products
Control group:Ultrasound therapy and treatment using control products
Sponsors
West China Hospital, Sichuan University
Eligibility
Sex/Gender
Female
Age
45 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Healthy Asian women; 2. Age> 45 years old; 3. Sagging of the lower part of the face on both sides (scored by the Skin Aging Atlas >=2); 4. Lack of firmness on both sides of the face (10-level score>=3 points and =2); 6. Ptosis of the upper and outer eyelids on both sides (scored by the Skin Aging Atlas >=2); 7. Obvious nasolabial folds on both sides (scored by the Skin Aging Atlas >=2); 8. Plan to undergo facial ultrasound treatment; 9. Understand the purpose and process of the research, and be able to understand it; 10. Willing and able to complete the entire pilot study and follow-up schedule; 11. Sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Pregnant or intending to become pregnant or not taking effective contraceptive measures during the study; 2. Any cutaneous or systemic disease (acute and/or chronic) (hyperthyroidism, psoriasis, eczema, acne, diabetes mellitus, severe heart, liver and kidney disease, coagulation dysfunction) and/or any local or systemic treatment that, in the opinion of the investigators, may interfere with the measured parameters; 3. Received any cosmetic, dermatological or surgical procedure (hyperthermia, chemical peel, filler, injection, lift, etc.) in the study area that may interfere with the study, or arranged such treatment during the study; 4. Have a history of allergy to the ingredients of the tested products; 5. Participate in another clinical trial or volunteers are in the exclusion stage of the trial, so they are unable to participate in the trial; 6. Those who cannot be contacted by telephone; 7. There are implants under the skin, such as metal, plastic, silicone and other implants, which may interfere with the therapeutic effect of Ultherapy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Lower sagging;crow's feet;Skin firmness;Upper and outer eyelid ptosis;Security assessment;nasolabial folds; | — |
Secondary
| Measure | Time frame |
|---|---|
| Skin stratum corneum moisture content;Skin roughness; | — |
Countries
China
Contacts
Public ContactLi Li
West China Hospital, Sichuan University
Outcome results
None listed